TABLE 3.
Cumulative Venous Thromboembolism (VTE) Recurrence Among Women Experiencing an Incident VTE Event, by VTE Type: Iowa Women's Health Study, 1986–2004
| Recurrenceb | No. of Recurrent VTE Events | No. of VTE Eventsa | Cumulative IR, % |
| VTE type | |||
| All VTE types, y | |||
| 1 | 58 | 1691 | 3.4 |
| 2 | 119 | 1691 | 7.0 |
| Idiopathic, y | |||
| 1 | 16 | 430 | 3.7 |
| 2 | 30 | 430 | 7.0 |
| Secondary, y | |||
| 1 | 42 | 1261 | 3.3 |
| 2 | 89 | 1261 | 7.1 |
| Secondary VTE type (all) | |||
| Cancer-related, y | |||
| 1 | 14 | 244 | 5.7 |
| 2 | 30 | 244 | 12.3 |
| Non–cancer related, y | |||
| 1 | 28 | 1017 | 2.8 |
| 2 | 59 | 1017 | 5.8 |
Note. IR = incidence rate.
Given the 6-month lag period required to define recurrence, only VTE patients not censored within the first 6 months after their incident event were eligible to have experienced a recurrent event (446 patients were censored, 366 who died and 80 who were no longer enrolled).
A 6-month lag period was required between the discharge date of the incident event and the admission date of the subsequent event to distinguish index events from recurrent events.